Journal of Addiction Research & Therapy
Open Access
Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 4859
Journal of Addiction Research & Therapy received 4859 citations as per Google Scholar report
Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- SafetyLit
- China National Knowledge Infrastructure (CNKI)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Journal of Addiction Research & Therapy : Citations & Metrics Report
Articles published in Journal of Addiction Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Addiction Research & Therapy has got h-index 34, which means every article in Journal of Addiction Research & Therapy has got 34 average citations.
Following are the list of articles that have cited the articles published in Journal of Addiction Research & Therapy.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
Total published articles |
88 | 88 | 61 | 59 | 24 | 28 | 24 | 59 | 48 |
Research, Review articles and Editorials |
20 | 68 | 49 | 7 | 8 | 18 | 0 | 0 | 0 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
68 | 0 | 1 | 15 | 3 | 1 | 0 | 0 | 0 |
Conference proceedings |
0 | 11 | 5 | 0 | 0 | 0 | 85 | 56 | 105 |
Citations received as per Google Scholar, other indexing platforms and portals |
90 | 168 | 573 | 612 | 590 | 545 | 567 | 473 | 440 |
| Journal total citations count | 4859 |
| Journal impact factor | 9.79 |
| Journal 5 years impact factor | 14.65 |
| Journal cite score | 13.41 |
| Journal h-index | 34 |
| Journal h-index since 2019 | 26 |
 |
Grimm MO, Mett J, Hartmann T (2016) The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´ s Disease. International Journal of Molecular Sciences 17: 1785. |
| View at Publisher | View at Google Scholar | |
|
Hori K, Konishi K, Tomioka H, Tani M, Minegishi G (2012) Reviews: Serum Anticholinergic Activity: A Biomarker for Rapid Progression of Alzheimer’s Disease. Autacoids S4 1: 2161-0479. |
| View at Publisher | View at Google Scholar | |
|
Hori K, Konishi K, Hosoi M, Tomioka H, Tani M,et al. (2016) Mini Review: Anticholinergic Activity as a Behavioral Pathology of Lewy Body Disease and Proposal of the Concept of “Anticholinergic Spectrum Disorders”. Parkinson’s Disease 22. |
| View at Publisher | View at Google Scholar | |
|
Mushtaq R, Pinto C, Tarfarosh SF, Hussain A, Shoib S, et al. (2016) A Comparison of the Behavioral and Psychological Symptoms of Dementia (BPSD) in Early-Onset and Late-Onset Alzheimer’s Disease-A Study from South East Asia (Kashmir, India). Cureus 8. |
| View at Publisher | View at Google Scholar | |
|
Nomura J, Hosoi T, Kaneko M, Ozawa K, Nishi A, Nomura Y (2016) Neuroprotection by Endoplasmic Reticulum Stress-Induced HRD1 and Chaperones: Possible Therapeutic Targets for Alzheimer’s and Parkinson’s Disease. Medical Sciences 4: 14. |
| View at Publisher | View at Google Scholar | |
|
Takata K, Kitamura Y (2012) Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer’s disease: Tangle formation, amyloid-β, and microglia in Alzheimer’s disease. Journal of pharmacological sciences 118: 331-337. |
| View at Publisher | View at Google Scholar | |
|
Singh BM, Mohanvir K, Nishit G, Kumar BV. RESEARCH AND REVIEWS: JOURNAL OF MEDICAL AND HEALTH SCIENCES. |
| View at Publisher | View at Google Scholar | |
|
Bhattacharjee P, Bhattacharyya D (2015) An Enzyme from Aristolochia indica Destabilizes Fibrin-β Amyloid Co-Aggregate: Implication in Cerebrovascular Diseases. PloS one 10: e0141986. |
| View at Publisher | View at Google Scholar | |
|
Blum K, Downs BW, Dushaj K, Li M, Braverman ER, et al. (2016) THE BENEFITS OF CUSTOMIZED DNA DIRECTED NUTRITION TO BALANCE THE BRAIN REWARD CIRCUITRY AND REDUCE ADDICTIVE BEHAVIORS. Precision medicine 1: 18. |
| View at Publisher | View at Google Scholar | |
|
Blum K, Femino J, Teitelbaum S, Giordano J, Oscar-Berman M, Gold M (2013) Molecular Neurobiology of Recovery with the Twelve Steps. InMolecular Neurobiology of Addiction Recovery: 11-82. |
| View at Publisher | View at Google Scholar | |
|
Ahmed Saadani Hassani MD, Marston BJ, Kaplan JE (2015) HHS Public Access. J Acquir Immune Defic Syndr 68: S257-S269. |
| View at Publisher | View at Google Scholar | |
|
Blum K, Febo M, D Badgaiyan R, R Braverman E, Dushaj K, et al. (2016) Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and Neuroplasticity. Current Pharmaceutical Design 22: 5837-5854. |
| View at Publisher | View at Google Scholar | |
|
Uddin MS, Al Mamun A, Sarwar MS, Chaity NH, Haque A, Akter N, Amran MS. Medicine that Causes Memory Loss: Risk of Neurocognitive Disorders. |
| View at Publisher | View at Google Scholar | |
|
Vitali M, Napolitano C, Berman MO, Minuto SF, Battagliese G, et al. (2016) Neurophysiological Measures and Alcohol Use Disorder (AUD): Hypothesizing Links between Clinical Severity Index and Molecular Neurobiological Patterns. Journal of addiction research & therapy 5. |
| View at Publisher | View at Google Scholar | |
|
Blum K, Badgaiyan R, Agan G, Fratantonio J, Gold MS (2014) Reward Deficiency Syndrome (RDS): Is there a Solution?. Journal of Alcoholism & Drug Dependence. |
| View at Publisher | View at Google Scholar | |
|
Blum K, Febo M, Fried L, Li M, Dushaj K, et al. (2017) Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With “Dopamine Homeostasis” in Reward Deficiency Syndrome (RDS). Substance Use & Misuse 52: 535-547. |
| View at Publisher | View at Google Scholar | |
|
Modestino EJ, Blum K, Oscar-Berman M, Gold MS, Duane DD, et al. (2015) Reward Deficiency Syndrome: Attentional/Arousal Subtypes, Limitations of Current Diagnostic Nosology, and Future Research. Journal of reward deficiency syndrome 1: 6. |
| View at Publisher | View at Google Scholar | |
|
Filipiak-Florkiewicz A, Topolska K, Florkiewicz A, Cieà âºlik E. Are Environmental Contaminants Responsible for ‘Globesity’?. |
| View at Publisher | View at Google Scholar | |
|
Blum K, Thanos PK, Oscar-Berman M, Febo M, Baron D, et al. (2015) Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction. Journal of reward deficiency syndrome 1: 95. |
| View at Publisher | View at Google Scholar | |
|
Canales JJ (2014) The Trace of Non-classical Biogenic Amines: A New Road to Addiction Recovery. J Addict Res Ther 4: 166. |
| View at Publisher | View at Google Scholar | |
